Submit Manuscript Now
Current issue Archive Authors Profile
Research Articles Issue 1 · 2021 · pp. 97–103 · Issue page

ANEMIA OF CHRONIC DISEASE - A DIAGNOSIS NOT ALWAYS EASY

DA
Daniela BADEA1
SM
Smaranda MITRAN2
AM
Amelia GENUNCHE-DUMITRESCU3
MA
Marius Cristian MARINAȘ4
AU
Aurelian Adrian BADEA5
TI
Tiberiu ȚENEA COJAN6
1 Clinical Hospital o f Emergency Craiova, Departme nt of Physiology, University of Medicine and Pharmacy Craiova, Romania
2 Department of Physiology, University of Medicine and Pharmacy of Craiova
3 Clinical Hospital of Emergency Craiova, Department of Internal Medicine, University of Medicine and Pharmacy of Craiova
4 Clinical Hospital of Emergency Craiova, Department of Anatomy, University of Medicine and Pharmacy of Craiova
5 Clinical Hospital of Emergency Bucharest, resident physician
6 CFR Hospital, Department of Surgery, University of Medicine and Pharmacy of Craiova
DOI https://doi.org/10.38173/RST.2021.21.1.9:97-103
Received 11 January 2021
Revised 15 February 2021
Accepted 06 March 2021
Available Online 15 March 2021
Abstract
ANEMIA OF CHRONIC DISEASE (ACD)- THE TYPE OF ANEMIA THAT IS THE SECOND MOST COMMON AFTER IRON-DEFICIENCY ANEMIA, AND IS CAUSED BY IMMUNITY 7. CYTOKINES AND CELLS OF THE RETICULOENDOTHELIAL SYSTEM INDUCE CHANGES IN: IRON HOMEOSTASIS, ERYTHROID PROGENITOR CELLS PROLIFERATION, ERYTHROPOIETIN PRODUCTION AND RED BLOOD CELL LIFE; ALL THIS CONTRIBUTES TO THE PATHO GENESIS OF ANEMIA. PARACLINICAL DIAGNOSIS OF ACD REVEALS NORMOCYTIC NORMOCHROMIC HYPOREGENERATIVE ANEMIA, OR MICROCYTIC HYPOCHROMIC HYPOREGENERATIVE ANEMIA. DIAGNOSIS OF OTHER TYPES OF S UCH ANEMIAS, IS NOT ALWAYS EASY.
Keywords
ANEMIA ERYTHROPOIETIN IRON-DEFICIENCY
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Chia Chi Sun, Valentina Vaja, Jodie L. Babitt, and Herbert Y. Lin , Targeting the hepcidin– ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation, Am. J. Hematol. 2012, 87:392–400.
[2]
Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation . Blood 2003;102: 783–788.
[3]
Ganz T, Nemeth E . Iron sequestration and anemia of inflammation . Semin Hematol 2009; 46:387–
[393]
11.
[4]
Gasche, C., Lomer, M.C., Cavill, I. & Weiss, G., Iron, anaemia and inflammatory bowel diseases . Gut, 2004, 53, 1190–1197.
[5]
Goodnough, L.T., Nemeth, E . & Ganz, T. Detection, evaluation and management of iron ‐restricted erythropoiesis. Blood 2010, 116, 4754–4761.
[6]
Guenter Weiss, M.D., and Lawrence T. Goodnoug h, M.D. Anemia of Chronic Disease . N Engl J Med 2005;352: 1011-23.
[7]
Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102: 1340-6. [Erratum, Blood 2004;103:4388.]
[8]
Laftah AH, Ramesh B, Simpson RJ, et al. Effect of hepcidin on intestinal iron absorptio n in mice . Blood 2004;103: 3940-4.
[9]
Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003;101: 4148-54.
[10]
Nemeth, E.  Ganz, T. The role of hepcidin in iron metabolism. Acta Haematologica, 122, 78-86.
[11]
Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 2002;282: G403-G414.
[12]
Ponka P, Cellular iron metabolism. Kidney Int Suppl.69:S2-11, 1999.
[13]
Skikne, B.S., Serum transferrin receptor. American Journal of Hematology, 2008, 83, 872–875.
[14]
Spivak JL, The blood in systemic disorders. Lancet355:1707-1712, 2000.
[15]
Thomas, C. & Thomas, L., Biochemical marker s and hematologic indices in the diagnosis of functional iron deficiency. Clinical Chemistry, 2002, 48, 1066–1076
[16]
Tong X, Kawabata H, Koeffler HP , Iron deficiency canupregulate expression of transferrin receptor at both the mRNA and proteinlevel. Br J Haematol 116:458-464, 2002.
[17]
Yasuda Y, Fujita Y, Matsuo T, et al. Erythropoietin regulates tu mour growth of human malignancies. Carcinogenesis 2003; 24:1021-9. Erratum, Carcinogenesis 2003; 24:1567.
[18]
Weiss, G. & Goodnough, L.T. Anemia of chronic disease. New Eng land Journal of Medicine 2005 ; 352: 1011–1023.
[19]
Wilson A, Rey es E, Ofman J. Prevalence and outcomes of anemia i n inflammatory bowel disease: a systematic review of the literature. Am J Med 2004;116: Suppl 7A:44S49S.
[20]
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352: 1011–1023.